BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3052302)

  • 21. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
    Figlin RA; deKernion JB; Maldazys J; Sarna G
    Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H; Machida T; Masaoka T; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):913-20. PubMed ID: 3885862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interferon-alpha therapy for hairy cell leukemia and lymphoproliferative disorders simulating hairy cell leukemia (hairy cell leukemia variant): a cooperative group study in Japan].
    Machii T; Kitani T; Kimura K; Maekawa I; Matsuzaki M; Mikuni C; Niikawa K; Igarashi T; Abe T; Miura Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2029-36. PubMed ID: 3070073
    [No Abstract]   [Full Text] [Related]  

  • 26. [Successful treatment of an adult T-cell leukemia with alpha-interferon].
    Fujimoto T; Imamura N; Saito O; Fujimura K; Okada K; Kuramoto A
    Rinsho Ketsueki; 1988 Sep; 29(9):1476-81. PubMed ID: 3216519
    [No Abstract]   [Full Text] [Related]  

  • 27. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
    Sarna G; Figlin R; Callaghan M
    J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
    Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
    Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+].
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Schwarzenberg L; Machover D; Ribaud P; de Vassal F
    Biomed Pharmacother; 1982 Mar; 36(2):112-6. PubMed ID: 7126777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current status and problems of cancer treatment with interferon].
    Ichikawa H
    Gan No Rinsho; 1983 May; 29(6):616-9. PubMed ID: 6876430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
    Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
    Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on interferon in cancer therapy in Japan].
    Ohno R
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The therapy of renal cell carcinoma with human lymphoblastoid interferon].
    Masuda F; Suzuki M; Ikemoto I; Yamazaki H; Machida T
    Hinyokika Kiyo; 1984 May; 30(5):615-9. PubMed ID: 6206703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
    Takeyama H; Yano K; Kataoka T; Yamamoto M; Emi N; Kodera Y; Kawashima K; Ohno R; Yokomaku S; Kobayashi M
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
    Foon KA; Bunn PA
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K; Yamada K; Yoshida T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.